TickerFacts.

Tenaya Therapeutics, Inc. (TNYA): Net Income

Annual figures by period end, from SEC filings.

-$90.60M
Year ended 2025-12-31
-$103.11M
Trailing 12 months to 2026-06-30
2020-12-31: -$38.40M2021-12-31: -$72.72M2022-12-31: -$123.67M2023-12-31: -$124.08M2024-12-31: -$111.13M2025-12-31: -$90.60M-$90.60M
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$90.60Mn/m2026-03-11, From 2025-01-01
2024-12-31-$111.13Mn/m2026-03-11, From 2024-01-01
2023-12-31-$124.08Mn/m2025-03-10, From 2023-01-01
2022-12-31-$123.67Mn/m2024-03-18, From 2022-01-01
2021-12-31-$72.72Mn/m2023-03-08, From 2021-01-01
2020-12-31-$38.40Mn/a2022-03-23, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Tenaya Therapeutics, Inc. (TNYA)2025-12-31-$90.60Mn/m
Inhibrx Biosciences, Inc. (INBX)2025-12-31-$140.06Mn/m
Black Diamond Therapeutics, Inc. (BDTX)2025-12-31$22.37Mn/m
ImageneBio, Inc. (IMA)2025-12-31-$45.35Mn/m
Precision Biosciences Inc (DTIL)2025-12-31-$45.72Mn/m
Compugen Ltd (CGEN)2025-12-31$35.34Mn/m
Palisade Bio, Inc. (PALI)2025-12-31-$16.78Mn/m
Artiva Biotherapeutics, Inc. (ARTV)2025-12-31-$83.86Mn/m
Cabaletta Bio, Inc. (CABA)2025-12-31-$167.86Mn/m

Compare TNYA, INBX, BDTX, IMA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗